pipette
ESEspañol

Milestone cancer vaccine success leaves hard questions unanswered

Jocelyn Kaiser

Peer-reviewed journalBroad interestReal-world useEasy to read

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Messenger RNA vaccine from Merck and Moderna slashes risk of melanoma’s return, but why remains unclear

Appeared: Saturday, October 31. Science. Peer-reviewed journal.

DOI: 10.1126/science.aen6356